Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of BDTX-189, an Orally Available Allosteric ErbB Inhibitor, in Patients With Advanced Solid Tumors.

Black Diamond Therapeutics, Inc. · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
breastcancergeneslungcancersmallcelllungcancer
solid tumor, her2 mutation, exon 20 insertion mutation, her2 positive, genes, her2, genes, erbb2, her2 amplification, her2 overexpression, genes, exon 20 insertion, lung cancer, non-small cell lung cancer, breast cancer
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 841935
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.